WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 14.062 ↓ -1.22%
[as on 13 February, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth and its peers as on 13 February, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth -1.03% -1.22% 2.34% -0.71% -3.73% 9.68%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -3.44% -1.05% 0.6% -1.55% -4.72% 1.29% 13.92% 16.69% 16.2% 16.86%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -1.92% -0.96% -0.17% -0.93% -1.11% 10.24% 14.69% 12.18% 14.56% 14.93%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH -0.71% -1.01% 1.53% -0.77% -3.47% 3.79% 25.54% 16.87% 21.41% 13.46%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -1.43% -1.21% -0.35% 1.76% -1.33% 8.93% 22.39% 21.1% 21.08% 18.32%
SBI PSU Fund - DIRECT PLAN - GROWTH 5.59% -1.19% 1.43% 5.81% 6.15% 30.1% 35.14% 29.88% 23.35% 18.01%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns---------1.44%

Discrete returns (monthly)

MonthApr 2025May 2025Jun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026
Returns2.86%0.9%4.42%4.66%-0.34%-1.84%3.06%0.25%-2.53%-5.38%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns5.07%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
90.88% 3.67% (Arbitrage: 0.00%) 0.00% 0.00% 5.45%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology7.82%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.87%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology6.48%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services6.32%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology4.68%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology4.20%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.82%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.73%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.94%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services2.73%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services2.64%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.16%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.13%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.95%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services1.88%
Jupiter Life Line Hospitals LimitedJLHL (INE682M01012)Healthcare Services1.80%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.67%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology1.64%
Kovai Medical Center and Hospital LimitedINE177F01017Healthcare Services1.63%
Alembic Pharmaceuticals LimitedAPLLTD (INE901L01018)Pharmaceuticals & Biotechnology1.56%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.52%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology1.52%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services1.48%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology1.43%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.34%
Eris Lifesciences LimitedERIS (INE406M01024)Pharmaceuticals & Biotechnology1.29%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.19%
Shaily Engineering Plastics LimitedSHAILY (INE151G01028)Industrial Products1.19%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology1.18%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology1.13%
Strides Pharma Science LimitedSTAR (INE939A01011)Pharmaceuticals & Biotechnology1.10%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies1.07%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services0.96%
Navin Fluorine International LimitedNAVINFLUOR (INE048G01026)Chemicals & Petrochemicals0.85%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.85%
Dr.Agarwals Eye Hospital LimitedINE934C01018Healthcare Services0.79%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.77%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.61%
Zota Health Care LimitedZOTA (INE358U01012)Pharmaceuticals & Biotechnology0.56%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology0.49%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services0.48%
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology0.43%

Debt

NameRatingWeight %
364 Days Tbill (MD 18/12/2025)Sovereign1.03%
182 Days Tbill (MD 25/12/2025)Sovereign1.03%
91 Days Tbill (MD 15/01/2026)Sovereign0.45%
91 Days Tbill (MD 04/12/2025)Sovereign0.41%
91 Days Tbill (MD 20/11/2025)Sovereign0.21%
91 Days Tbill (MD 28/11/2025)Sovereign0.21%
364 Days Tbill (MD 11/12/2025)Sovereign0.21%
91 Days Tbill (MD 08/01/2026)Sovereign0.12%
Portfolio data is as on date 31 October, 2025

NAV history

WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth - 30 days NAV (Net asset value) history

DateNAV
13 February, 202614.062
12 February, 202614.236
11 February, 202614.253
10 February, 202614.079
9 February, 202614.027
6 February, 202613.741
5 February, 202613.790
4 February, 202613.811
3 February, 202613.830
2 February, 202613.444
30 January, 202613.532
29 January, 202613.387
28 January, 202613.516
27 January, 202613.491
23 January, 202613.493
22 January, 202613.648
21 January, 202613.517
20 January, 202613.633
19 January, 202613.931
16 January, 202614.031
14 January, 202614.167
13 January, 202614.163
12 January, 202614.122
9 January, 202614.216
8 January, 202614.362
7 January, 202614.553
6 January, 202614.488
5 January, 202614.335
2 January, 202614.344
1 January, 202614.209

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The latest NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 14.062 as on 13 February, 2026.
  • What are YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are -1.03% as on 13 February, 2026.
  • What are 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 9.68% as on 13 February, 2026.